缅北强奸

Overview of the Car-T Program at the MUHC

Speaker: Dr. Michael Sebag, MD, PhD, FRCPC

Associate Professor of Medicine,聽Division of Hematology
Medical Director, Immune Effector Cell Therapy,聽缅北强奸 Health Center

At the end of the presentation, the audience will:

1. Get familiar with CarT cells in hematologic oncologies.
2. Discuss the future applications of CarT therapies.
3. Learn the processes that were established for regulatory and safety purposes.
4. Review our institution鈥檚 outcomes.

Zoom link:

Full MUHC Grand Rounds Schedule